Enzyme replacement therapy for mucopolysaccharidosis VI: Long-term cardiac effects of galsulfase (Naglazyme®) therapy - Braunlin, E.; Rosenfeld, H.; Kampmann, C.; Johnson, J.; Beck, M.; Giugliani, R.; Guffon, N.; Ketteridge, D.; SáMiranda, C. M.; Scarpa, M.; Schwartz, I. V.; Leão Teles, E.; et al. (Journal of Inherited Metabolic Disease, 2013)